Palbociclib (Standard)
Based on 1 Customer Validation
Palbociclib (Standard) is the analytical standard of Palbociclib. This product is intended for research and analytical applications. Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.23%
- CAS. Nr.: 571190-30-2
- Formel: C24H29N7O2
- Molecular Weight:447.53
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-15772
OsimertinibMutant-Selective EGFR Inhibitor -
HY-50767
PalbociclibCDK4/6 Inhibitor -
HY-15777R
Ribociclib (Standard)CDK4/6 Inhibitor -
HY-16297AR
Abemaciclib (Standard)CDK4/6 Inhibitor -
HY-10162
OlaparibPARP Inhibitor -
HY-12529
Ro-3306CDK1 Inhibitor -
HY-103019A
(±)-EnitociclibCDK9 Inhibitor -
HY-16297A
AbemaciclibCDK4/6 Inhibitor -
HY-15777
RibociclibCDK4/6 Inhibitor -
HY-A0065
Palbociclib isethionateCDK4/6 Inhibitor -
HY-10331
RegorafenibMulti-kinase Inhibitor -
HY-B0028
Fludarabine phosphateApoptosis Inducer
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 571190-30-2
-
Appearance Solid
-
Molecular Weight 447.53
-
Formel C24H29N7O2
-
Color Light yellow to yellow
-
SMILES
O=C1C(C(C)=O)=C(C2=CN=C(N=C2N1C3CCCC3)NC4=CC=C(N5CCNCC5)C=N4)C
-
Synonyms
PD 0332991 (Standard)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
SDS (623 KB)
- English - EN (623 KB)
- Français - FR (623 KB)
- Deutsch - DE (623 KB)
- Norwegian - NO (623 KB)
- Español - ES (623 KB)
- Swedish - SV (623 KB)
- Italian - IT (623 KB)
- Korean - KR (623 KB)
- Portuguese - PT (623 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Fry DW, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 2004 Nov;3(11):1427-38. [Content Brief]
[2]. Goel S, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017 Aug 24;548(7668):471-475. [Content Brief]
[3]. Richard S Finn, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77. [Content Brief]
[4]. Bollard J, et al. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut. 2017 Jul;66(7):1286-1296. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Palbociclib (Standard) Related Classifications
HY-50767R Related Classifications
Powered by Bioz